Products

Portfolio products

Buprenorphine HCl

CAS No.: 53152-21-9

Specification: Ph.Eur & USP

Regulatory Status: CEP + USDMF (applied)

EU SDS

Dexamfetamine sulphate

CAS No.: 51-63-8

Specification: Ph.Eur

Regulatory Status: CEP

EU SDS

Buprenorphine

CAS No.: 52485-79-7

Specification:

Regulatory Status: CEP + USDMF (applied)

EU SDS

Dexamfetamine (base)

CAS No.: 51-64-9

Specification: Ph.Eur

Regulatory Status: Starting material

EU SDS

Tolfenamic Acid

CAS No.: 13710-19-5

Specification: Ph.Eur

Regulatory Status: CEP

EU SDS

Hydromorphone HCL

CAS No.: 71-68-1

Specification: Ph.Eur

Regulatory Status: CEP

EU SDS

Lisdexamfetamine dimesylate

CAS No.: 608137-33-3

Specification: N/A

Regulatory Status: DMF

EU SDS

Products under development

Apomorphine HCl

CAS No.: 41372-20-7

Specification: Ph.Eur

Regulatory Status: N/A

EN SDS

Sugammadex

CAS No.: 343306-79-6

Specification: Ph.Eur

Regulatory Status: N/A

Naloxone

CAS No.: 357-08-4

Specification: Ph.Eur

Regulatory Status: N/A